×
About 593 results

ALLMedicine™ Oncology Treatment Center

Research & Reviews  178 results

Two-dimensional metal-organic frameworks: from synthesis to bioapplications.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059454
Journal of Nanobiotechnology; Wang W, Yu Y et. al.

May 4th, 2022 - As a typical class of crystalline porous materials, metal-organic framework possesses unique features including versatile functionality, structural and compositional tunability. After being reduced to two-dimension, ultrathin metal-organic framewo...

Efficacy of open dialogue about complementary and alternative medicine compared with st...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039403
BMJ Open; Stie M, Delmar C et. al.

Apr 27th, 2022 - Complementary and alternative medicine (CAM) has been shown to reduce symptoms and adverse effects and improve quality of life of patients undergoing conventional oncology treatment, but CAM might also cause symptoms and adverse effects such as he...

Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatmen...
https://doi.org/10.1016/j.clon.2022.03.012
Clinical Oncology (Royal College of Radiologists (Great B... Hanna CR, Lemmon E et. al.

Apr 5th, 2022 - The Short Course Oncology Treatment (SCOT) trial indicated that 3 months of adjuvant doublet chemotherapy was non-inferior to 6 months of treatment for patients with colorectal cancer, with considerably less toxicity. The SCOT trial results were d...

Nephrotoxic Effects of Chemotherapeutic Agents.
https://doi.org/10.1188/22.CJON.219-223
Clinical Journal of Oncology Nursing; Drury Z, Ly T et. al.

Mar 19th, 2022 - Nephrotoxicity can be a severe complication of oncology treatment. The most common presentations of chemotherapy-related renal disorders include acute kidney injury, electrolyte abnormalities, acid base disturbances, hemolytic anemia, and hyperten...

Adolescent Medical Decisionmaking Rights: Reconciling Medicine and Law.
https://doi.org/10.1017/amj.2022.2
American Journal of Law & Medicine; Coleman DL, Rosoff PM

Mar 18th, 2022 - Dennis Lindberg came into his aunt's care when he was in the 4th grade because his parents struggled with drug addiction and could not provide for him. At thirteen, he was baptized in his aunt's faith as a Jehovah's Witness. Just days after he tur...

see more →

Guidelines  1 results

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and ...
https://doi.org/10.1016/j.kint.2020.06.046
Kidney International; Porta C, Bamias A et. al.

Nov 1st, 2020 - The association between kidney disease and cancer is multifaceted and complex. Persons with chronic kidney disease (CKD) have an increased incidence of cancer, and both cancer and cancer treatments can cause impaired kidney function. Renal issues ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  5 results

The Canadian/US Integrative Oncology Study
https://clinicaltrials.gov/ct2/show/NCT02494037

Oct 21st, 2021 - It is estimated that between 50 and 80% of cancer patients in the United States (US) supplement their conventional oncology treatment regimen with some form of complementary or alternative medicine therapy or practice. A smaller percentage of thes...

Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas
https://clinicaltrials.gov/ct2/show/NCT03590210

Feb 21st, 2021 - Undoubtedly, there is a strong medical need for new efficacious therapies for patients with advanced soft tissue sarcomas. While immune oncology treatment approaches like inhibition of immune checkpoints by administration of anti PD-1 / PD-L1 anti...

Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematological Malignancies
https://clinicaltrials.gov/ct2/show/NCT02164071

Nov 18th, 2019 - The elderly comprise the most prevalent population in oncology practice. The available evidence suggests that old patients are undertreated patients, mainly because of their advanced age, regardless of whether they are highly functional patients, ...

Patient Rheumatoid Arthritis Social Support Study
https://clinicaltrials.gov/ct2/show/NCT01525654

Feb 26th, 2019 - Rheumatoid arthritis (RA) is a chronic disabling disease that affects nearly 1% of the U. S. population [1]. The illness causes destruction of joint cartilage and erosion of adjacent bone, leading to joint replacement as well as extra-articular di...

The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
https://clinicaltrials.gov/ct2/show/NCT03793322

Jan 4th, 2019 - This study aims to evaluate the feasibility of indocyanine green (ICG)-based fluorescence imaging in the detection of liver tumors. By correlating the ICG fluorescence patterns with pathologically confirmed tumors , it would be possible to use flu...

see more →

News  51 results

FDA Grants Priority Review to Toripalimab for Nasopharyngeal Carcinoma
https://www.onclive.com/view/fda-grants-priority-review-to-toripalimab-for-nasopharyngeal-carcinoma

Nov 1st, 2021 - The FDA has accepted for review a biologics license application (BLA) for the use of toripalimab in combination with gemcitabine and cisplatin in the frontline treatment of patients with advanced recurrent or metastatic nasopharyngeal carcinoma, a...

Now Takeda Offers Rebate if Lung Cancer Drug Fails to Work
https://www.medscape.com/viewarticle/961710

Oct 27th, 2021 - Takeda Pharmaceuticals is now the latest pharmaceutical company to offer a value-based agreement on one of its new targeted therapies. The rebate offer is for brigatinib (Alunbrig) which is approved for the treatment of adults with anaplastic lymp...

Bioengineered Models Could Improve Understanding of Bone Cancer, Metastases
https://www.onclive.com/view/bioengineered-models-could-improve-understanding-of-bone-cancer-metastases

Oct 6th, 2021 - Tissue-engineered platforms could pave the way for a deeper understanding of cancer arising in or metastasizing to the bone and ultimately lead to targeted therapeutic developments, according to a review published in the Journal of Biomechanics. ...

Dermatology Expert Discusses Challenges Facing Cancer Patients
https://www.onclive.com/view/dermatology-expert-discusses-challenges-facing-cancer-patients

Oct 6th, 2021 - Mario E. Lacouture, MD Dermatologist Memorial Sloan-Kettering Cancer Center New York, NY Skin conditions can affect patients throughout their cancer trajectory, emerging or persisting even after treatment ends. Novel therapies als...

CMS' 340B Reform Effort Shakes Up Hospital-Clinic Partnerships
https://www.onclive.com/view/cms-340b-reform-effort-shakes-up-hospital-clinic-partnerships

Oct 6th, 2021 - Teri U. Guidi, MBA Following a multiyear trend in which oncology practices merged with hospitals to achieve savings and improved care, it appeared as though the pendulum was going to swing the other way. The Centers for Medicare & Medicaid Servic...

see more →